EMN

Eastman Chemical Co. 10-Q Summary: Period Ended June 30, 1997

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Eastman Chemical Company for the period ended June 30, 1997. The company operates in three primary segments: Specialty and Performance, Core Plastics, and Chemical Intermediates. The report covers the second quarter and the first six months of 1997, comparing results to the same periods in 1996.

Key Financial Metrics

Margins (6 Months 1997): Gross Margin was 22.8% (down from 25.6% in 1996). Operating Margin was 12.2% (down from 15.2% in 1996).

Material Changes vs. Prior Period

• Revenue Decline: Sales decreased 3% in Q2 and 5% year-to-date (YTD) primarily due to significantly lower selling prices for EASTAPAK polyethylene terephthalate (PET) and lower unit volumes in fibers and fine chemicals. This was partially offset by volume gains in container plastics and coatings.
• Earnings Decline: Net earnings fell 20% in Q2 and 28% YTD. The primary drivers were lower selling prices, increased distribution costs (due to interregional product movement prior to new facility completion), and higher propane feedstock costs.
• Segment Performance:
  • Specialty and Performance: Sales flat YTD; operating earnings down 4% due to demand volatility and lower acetate tow volumes.
  • Core Plastics: Sales down 16% YTD; operating earnings swung from a $48M profit to a $25M loss, driven by lower PET prices and limited ethylene availability affecting TENITE polyethylene volumes.
  • Chemical Intermediates: Sales up 3% YTD; operating earnings down 9% due to lower oxo chemical prices and higher propane costs.
• Foreign Currency: Estimated negative impact of $8 million in Q2 and $14 million YTD on net earnings.

Guidance, Outlook, and Risks

• Outlook: Management expects continued good demand in 1997.
  • Specialty and Performance: Low single-digit revenue gains; slightly lower operating margins due to pricing pressure.
  • Core Plastics: Double-digit volume growth expected, but flat revenues and negative earnings comparisons vs. 1996 due to persistent PET pricing pressure.
  • Chemical Intermediates: Modest volume growth expected to offset lower prices; margins relatively flat.
• Capital Program: Total 1997 capital expenditures anticipated at approximately $850 million for global capacity expansion. Depreciation expected to be ~$330 million.
• Liquidity: The company has an $800 million revolving credit facility (unused) and $244 million in commercial paper outstanding. A $300 million issuance of 7.60% debentures in early 1997 was used to repay commercial paper.
• Share Repurchases: No repurchases in Q2. Management does not expect significant additional repurchases in 1997 due to the capital expenditure program.
• Risks: Forward-looking statements are subject to risks including inaccurate assumptions about market conditions, raw material availability, and capacity additions. Legal proceedings are ongoing but not expected to have a material adverse effect.

Investor Verification Checklist

• Verify the sustainability of the pricing pressure on EASTAPAK PET and the timeline for new international manufacturing facilities to reduce distribution costs.
• Confirm the impact of the recently completed ethylene pipeline on TENITE polyethylene volumes in the second half of 1997.
• Monitor the $850 million capital expenditure program and its effect on future depreciation and cash flow.
• Review the $100 million "Advantaged Cost 2000" initiative targets for labor and material productivity gains.
• Assess the company's ability to maintain liquidity given the high level of long-term borrowings ($1,766 million) and the shift away from share repurchases.